Skip to content

Benefit of Paramedical Care in Accompanying Caregivers of Patients That Had Surgery for an Head and Neck Invasive Cancer

Benefit of Paramedical Care in Accompanying Caregivers of Patients That Had Surgery for an Head and Neck Invasive Cancer

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05542706
Acronym
AIDORL
Enrollment
76
Registered
2022-09-15
Start date
2022-10-31
Completion date
2027-10-31
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Brief summary

Head and Neck invasive cancer usually requires surgery that is associated with modifications of the body structure of patient regarding breathing, eating and communication. These modifications are correlated with an important loss of autonomy in patients. During the study, while the patient is hospitalised after the surgery, the paramedical team will train the caregiver of the patient from experimental group a new dimension of autonomy in order to assure a safe return home. The level of learning depends on each caregiver and patient; therefore, an adapted training is provided. This study evaluates the impact of paramedical care in accompanying caregivers of patients that had surgery for an ENT invasive cancer, by comparing the experimental group (paramedical care) to the standard group (standard care). The hypothesis of the study is that a benefit will be seen in the experimental group, by reducing the caregiver burden, improving the quality of life of patients and lowering the rate of hospitalisations and prolonged hospitalisations in these patients.

Interventions

OTHERAccompanying caregivers by paramedical team

At each study visit (baseline, one week after hospital discharge, 4-8 weeks after surgery, 8-12 weeks after surgery and 16-20 weeks after surgery), the paramedical team have a dedicated meeting with the caregiver of the patient (at hospital or remote) and teach them the care procedures needed in accompanying the patient and the evaluate the learning progress. The training is adapted to each caregiver, according to his/her motivation and his/her ability. The goal is to have the training regarding the enteral nutrition, prevention of dehydration, pain management.

Sponsors

Centre Henri Becquerel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Patients : * Age between 18 and 85 years old * ECOG ≤ 2 * Patient diagnosed with an head and neck squamous-cell carcinoma, stage T2-T4/N+, non-metastatic, localised at larynx, pharynx, oropharynx, oral cavity or maxillary, needing curative surgery, with indication of radiotherapy after surgery, in accordance to decision of the regular multidisciplinary meetings in cancerology * No ongoing measure of corrective justice for the patient * Informed consent form signed * Patient covered by health system

Exclusion criteria

* Patient scheduled for surgery after radiotherapy or for surgery on site already irradiated * Patient or caregiver that do not agree to participate in the study (the pair patient-caregiver is needed) * History of psychological or sensorial disorder or anomaly that can prevent the patient from understanding the conditions for study participation

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the impact of paramedical care on the caregiving burden between the two groupsAt 20 weeks after surgeryVia Zarit Burden Interview

Secondary

MeasureTime frameDescription
Comparison of the impact of paramedical care on the caregiving burden between the two groupsAt 8 weeks after surgeryVia Zarit Burden Interview
Measure of quality of life in the two groupsbaselineWHOQOL-26

Countries

France

Contacts

Primary ContactYveline David
yveline.david@chb.unicancer.fr+33232082542
Backup ContactDoriane Richard
doriane.richard@chb.unicancer.fr+33232082985

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026